Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jeffery L. Kutok
Age : 53
Public asset : 515,278 USD
Linked companies : Epizyme, Inc.
Summary 
Jeffery L. Kutok holds the position of Chief Scientific Officer & Executive VP at Epizyme, Inc.

In the past Dr. Kutok held the position of Chief Scientific Officer & Senior Vice President at Infinity Pharmaceuticals, Inc., Associate Professor-Pathology at The Brigham & Women's Hospital, Inc. and Associate Professor-Pathology at Harvard Medical School.

He received an undergraduate degree, a doctorate and a graduate degree from Stony Brook University.


Current positions of Jeffery L. Kutok 
NameTitle Since
Epizyme, Inc.
(Biotechnology & Medical Research)
Chief Scientific Officer & Executive VP 2020


Holdings of Jeffery L. Kutok 
NameEquities%Valuation
Epizyme, Inc. (EPZM)
(Biotechnology & Medical Research)
99,8600.098%515,278 USD


Jeffery L. Kutok: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Jeffery L. Kutok : Connections